Scientists on Wednesday unveiled a synthetic drug that appears to neutralise pain as effectively as morphine but without the side-effects that make opioids so dangerous and addictive.
The big-data methods used by the researchers also open up a promising avenue in drug innovation, they reported in the journal Nature.
In experiments with mice, the new compound – identified after screening "trillions" of candidates – activated a known molecular pathway in the brain that triggers pain suppression.
But unlike morphine and prescription drugs such as oxycodone or oxycontin, it did not switch on a second pathway that can slow or block normal breathing.
Respiratory suppression caused by opioids results in some 30,000 deaths every year in the United States alone, where opioid use and abuse has taken on epidemic proportions.
Nor did the new drug – dubbed PZM21 – produce addiction in the lab mice, which get hooked on morphine and pharmaceutical painkillers as easily as humans.
In experiments, the rodents showed no preference between a cubicle in which they had been administered PZM21 or one in which they received a neutral saline solution.
PZM21, the researchers summed up, offers "long-lasting analgesia coupled to apparent elimination of respiratory depression."
A third advantage of the new compound, they said, is that it does not cause constipation. In the United States, drugs designed to relieve blocked bowels due to opioids are advertised on television.
Opium and its derivatives have been used to dull pain (and generate euphoric feelings) for more than 4,000 years.
Even in the era of modern medicine, morphine – derived from the opium poppy – has remained the painkiller of choice, whether for post-op recovery or on the battlefield.
"But it is obviously dangerous too," said Brian Shoichet, a professor at the University of California's School of Pharmacy in San Francisco, and one of three senior authors of the study.
"People have been searching for a safer replacement for standard opioids for decades."
Most such efforts have tried to tweak the drug's chemical structure to get rid of the side-effects.
Shoichet and colleagues from Stanford University, the University of North Carolina and Friedrich-Alexander University in Bavaria, Germany took a radically different approach.
Towards 'the perfect drug'
They focused instead on the so-called opioid receptor in the brain which triggers a chemical reaction leading to pain suppression when activated.
Only a molecule that successfully "docks" with the receptor – like a key turning a lock – would work.
But to avoid addiction and respiratory failure, that same molecule must not, as does morphine, dock with a second receptor that provokes those unwanted reactions.
"With traditional forms of drug discovery, you're locked into a little chemical box," explained Shoichet.
"But when you start with the structure of the receptor you want to target, you can throw all those constraints away."
Using computer simulations, the researchers tested three million commercially available compounds – and a million possible configurations for each one – to see which would fit best with the receptor.
In the lab, combing through trillions of options would have been prohibitively expensive and time-consuming.
Some 2,500 molecules passed muster.
After eliminating those resembling opioids too closely, only 23 remained.
And only one of these, further analysis showed, activated the "good" molecular pathway without triggering the "bad" one. Even then, more custom-engineering was required.
"There is little doubt that structure-based computational screening will accelerate the pace of drug discovery," Brigitte Kieffer, a professor at McGill University's department of psychiatry commented in Nature.
The new research, she added, was "a step toward the perfect drug."
PZM21 still has many hurdles to overcome before showing up in pharmacies.
It must be proven safe for humans, and effective in clinical trials – a process that typically takes up to a decade.
Future research will also need to determine whether mice – or people – develop a tolerance to the drug, causing it to lose its painkilling potency over time.
AFP RELAXNEWS
Thu Aug 18 2016
Scientists have been searching for a safer alternative to opioid painkillers. - AFP Relaxnews
Amerika Syarikat mungkin haramkan firma dron China, DJI
Amerika Syarikat kini turut sedang pertimbangkan DJI sebagai ancaman sekuriti, dan mungkin melakukan perundangan untuk mengharamkan DJI.
Bersatu ambil tindakan susulan terhadap enam ahli Parlimen - Muhyiddin
Bersatu sedang melaksanakan tindakan susulan terhadap enam ahli Parlimennya yang menyokong Perdana Menteri selepas meminda Perlembagaan parti bulan lalu.
'Made in Malaysia' - Apple punyai 19 kilang pembekal di negara ini
Malaysia merupakan salah satu negara yang mempunyai beberapa kilang pembekal yang menawarkan komponen kepada Apple.
SPRM lancar bilik gerakan PRK Kuala Kubu Baharu
SPRM melancarkan bilik gerakan, bagi membolehkan orang ramai menyalurkan maklumat serta aduan berkaitan perbuatan rasuah dan salah guna kuasa.
WEF anjur mesyuarat khas di Arab Saudi ketika suhu geopolitik Asia Barat memanas
WEF keluar dari kelazimannya dengan menganjurkan mesyuarat khas dua hari, 28-29 April 2024 di Riyadh, Arab Saudi.
Kerajaan rangka hala tuju beri lebih banyak perlindungan kepada kanak-kanak
Kerajaan akan merangka hala tuju bagi memberikan lebih banyak perlindungan dari segi undang-undang kepada kanak-kanak di negara ini.
Tiada tepung di pasaran tempatan mengandungi benzoil peroksida melebihi kadar dibenarkan - KKM
Tiada mana-mana jenama tepung di pasaran tempatan mengandungi benzoil peroksida melebihi paras yang dibenarkan di bawah undang-undang.
Freedom Flotilla to Gaza: Semua delegasi diminta pulang, FFC akan maklumkan tarikh baharu misi
Menurut Jawatankuasa Pemandu FFC, Ann Wright, pihaknya akan memaklumkan perkembangan terbaharu kepada semua delegasi terlibat sekiranya tarikh akhir pelayaran ditetapkan.
Bytedance enggan jual TikTok di Amerika Syarikat
BYTEDANCE kini mengatakan mereka tidak akan menjual perniagaan TikTok di Amerika Syarikat (AS).
Malaysia komited tingkat hubungan dua hala bersama Libya
Malaysia terus komited mempertingkatkan hubungan dua hala yang berterusan bersama Libya demi manfaat bersama dalam pelbagai sektor.
Empat beradik terlibat dadah antara yang ditahan AADK
Ketua Pegawai AADK Daerah Kuala Muda, Arnida Ishak berkata, mereka yang berumur antara 28 dan 42 tahun itu tinggal bersama ibu dan dua kakak.